Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
05/2007
05/29/2007US7223791 Function regulator for retinoid relative receptor
05/29/2007US7223788 therapy for eating disorders, anorexigenic agents, antidiabetic agents, reducing weight in mammals, circadian rhythm disease, psychological disorders
05/29/2007US7223780 Triazole-derivatives as blood clotting enzyme factor Xa inhibitors
05/29/2007US7223573 Enzymatic ammonolysis process for the preparation of intermediates for DPP IV inhibitors
05/29/2007US7223355 Functional additive having UV-absorbing substituent and ink composition containing the same
05/24/2007WO2007059021A1 Soft anticholinergic zwitterions
05/24/2007WO2007058960A1 Sulfamoyl benzamides as cannabinoid receptor modulators
05/24/2007WO2007057755A1 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium
05/24/2007WO2007057703A2 Intermediate compounds for the preparation of statins
05/24/2007WO2007057658A1 Palladium catalysed heck arylation or vinylation of 1-substituted olefins
05/24/2007WO2007057139A1 Microbiocides
05/24/2007WO2007037513A9 Aryl-substituted nitrogen-containing heterocyclic compound
05/24/2007US20070117988 Reacting alkylsulfonyl chloride in presence of base, cyanating, deblocking
05/24/2007US20070117861 Treatment or prevention of cardiovascular and respiratory disorders with novel substituted cyclic-amp specific phosphodiesterase inhibitors
05/24/2007US20070117854 Malononitrile compounds and use thereof
05/24/2007US20070117852 (Hetero)cyclyl carboxanilides for controlling harmful fungi
05/24/2007US20070117807 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis
05/24/2007US20070117760 such as N-[5-({[5-({[3-(Dimethylamino)propyl]amino}carbonyl)-1-methyl-1H-pyrrol3-yl]amino}carbonyl)-1-isopropyl-1-H-pyrrol-3-yl]-4-[(3,3-dimethylbutanoyl)amino]-1-methyl-1H-pyrrole-2-carboxamide; oligopeptides; competitive binding
05/24/2007US20070117740 3-(2-hydroxyphenyl)-2-propenamides that react to form a lactone and an amine; laundry detergents, perfumes, shampoos and hair conditioners
05/24/2007DE102005054038A1 Pyroglutaminsäureester mit verbesserter biologischer Abbaubarkeit Pyroglutamic esters having improved biodegradability
05/24/2007CA2630507A1 Intermediate compounds for the preparation of statins
05/24/2007CA2627982A1 Soft anticholinergic esters
05/23/2007EP1787984A2 Azacyclic compounds for use in the treatment of serotonin related diseases
05/23/2007EP1787981A1 New N-phenethylcarboxamide derivatives
05/23/2007EP1786771A1 Novel polymorphs of the potassium salt of atorvastatin
05/23/2007EP1786770A1 N-(1-(2,3-dihydro-1h-inden-5yl) -2-oxo-3-pyrrolidinyl) -sulfonamide derivatives for use as factor xa inhibitors
05/23/2007EP1786769A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
05/23/2007EP1786768A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions
05/23/2007EP1786766A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
05/23/2007EP1786416A1 Sulpiride derivatives pharmaceutical compositions
05/23/2007EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
05/23/2007EP1185264B1 Process for the production of amorphous atorvastatin calcium
05/23/2007EP1181014B1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD
05/23/2007CN1968928A Heterocyclic derivatives for treatment of hyperlipidemia and related diseases
05/23/2007CN1968924A Pyrrolidin-3-yl compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
05/23/2007CN1968923A Method for producing acetamidopyrrolidine derivative and intermediate compound thereof
05/23/2007CN1968922A 因子xa抑制剂 Factor xa inhibitors
05/23/2007CN1317267C Imide sulfo N-hydroxy maleopimarate as light acid producing agent and its synthetic method
05/22/2007US7220884 Hydroaminomethylation of olefins
05/22/2007US7220869 To be used as acidic catalysts
05/22/2007US7220773 Heterocylic amines used as antidiabetic or hyperglycemic agents
05/22/2007US7220759 Isoquinoline compound and pharmaceutical use thereof
05/22/2007CA2276694C New fatty acid derivatives
05/22/2007CA2157146C Heterocyclyl-benzoylguanidines
05/18/2007WO2007056469A2 Certain chemical entities, compositions, and methods
05/18/2007WO2007054896A1 Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
05/18/2007WO2007054790A1 Process for preparation of (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
05/18/2007WO2007054225A2 Pyroglutamic acid esters with improved biodegradability
05/18/2007WO2007054128A1 Novel inhibitors of the lfa-1/icam-1 interaction, and uses thereof
05/18/2007WO2007034012A3 Method of obtaining amorphous calcium atorvastatin
05/18/2007WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors
05/18/2007WO2006028525A3 [3.2.0] heterocyclic compounds and methods of using the same
05/18/2007CA2627599A1 Process for (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
05/18/2007CA2627594A1 Process for preparation of (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
05/17/2007US20070112205 Cyanopyrrolidine derivatives
05/17/2007US20070112059 Cyanopyrrolidine derivatives
05/17/2007US20070112030 Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto
05/17/2007US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma
05/16/2007EP1784389A1 Process for atorvastatin calcium amorphous
05/16/2007EP1784388A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
05/16/2007EP1588145A4 Methods, mixtures, kits and compositions pertaining to analyte determination
05/16/2007EP1303307B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents
05/16/2007CN1964970A Iap的抑制剂 Iap inhibitors
05/16/2007CN1964957A Anionic-sweetener-based ionic liquids and methods of use thereof
05/16/2007CN1964943A Process for the preparation of n-akyl-pyrrolidones
05/16/2007CN1964942A Process for preparing 2-oxo-1-pyrrolidine derivatives by intramolecular allylation
05/16/2007CN1962634A Process for preparing N-phenyl maleimide
05/16/2007CN1962633A Process for preparing N-cyclohexyl maleimide
05/16/2007CN1315805C Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins
05/16/2007CN1315804C New synthesis process of sultopride hydrochloride
05/15/2007US7217826 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate
05/15/2007US7217740 Diarylsulfones as 5-HT2A antagonists
05/15/2007US7217733 Cardiovascular disorders; kidney disorders; antiinflammatory agents
05/15/2007US7217728 For therapy of reperfusion injury
05/15/2007US7217707 Amide of R-2-(aminoaryl)-propionic acid for use in the prevention of leucocyte activation
05/15/2007US7217575 Avidin derivatives and uses thereof
05/15/2007CA2155275C Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds
05/10/2007WO2007053819A2 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods
05/10/2007WO2007053452A1 Bi-aryl meta-pyrimidine inhibitors of kinases
05/10/2007WO2007053436A1 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor
05/10/2007WO2007053427A2 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
05/10/2007WO2007053145A1 Haloperidol analogs
05/10/2007WO2007052843A1 Heterocyclic amide compound and use thereof
05/10/2007WO2007052578A1 Process for production of benzyloxypyrrolidine derivative, and process for production of hydrochloride salt powder of optically active benzyloxypyrrolidine derivative
05/10/2007WO2007052517A1 Method for producing hydroxy-2-pyrrolidinecarboxyamide compound
05/10/2007WO2007052296A2 A process of preparing amorphous atorvastatin calcium
05/10/2007WO2007051738A1 Hydrogen-catalysed process for preparing (meth)acrylates of n-hydroxy­alkylated lactams
05/10/2007WO2006120574A3 Analogs of 4-hydroxyisoleucine and uses thereof
05/10/2007WO2006050265A3 Ceramides and apoptosis-signaling ligand
05/10/2007WO2002010431A3 Functional biopolymer modification reagents and uses thereof
05/10/2007US20070105935 Reacting 2-hydroxymethyl-n-protected-4-substituted pyrrolidine with arylsulfonyl chloride or an optionally substituted alkylsulfonyl chloride in the presence of a base; reacting with p-hydroxybenzenecarboxylic acid derivative (ethyl 4-(N-benzyloxycarbonyl-(4S)-methoxy-(2S)-pyrrolidinylmethoxy)benzoate)
05/10/2007US20070105933 Amino alcohol compounds
05/10/2007US20070105899 Benzene compounds
05/10/2007US20070105859 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors
05/10/2007US20070105858 Retinoic acid mimetic anilides
05/10/2007US20070105831 Carboxamide derivatives as muscarinic receptor antagonists
05/10/2007US20070105201 Process for the enantiomeric resolution of 1-substituted 2-(aminomethyl)-pyrrolidines by amidation in the presence of lipases
05/10/2007DE102005052931A1 Katalytisches Verfahren zur Herstellung von (Meth)acrylaten von N-hydroxyalkylierten Lactamen Catalytic process for the preparation of (meth) acrylates of N-hydroxyalkylated lactams
05/10/2007DE102005051977A1 Neue 2,4-Dichlorphenoxyessigsäurederivate und deren Verwendung in diagnostischen und analytischen Nachweisverfahren New 2.4-dichlorophenoxyacetate and their use in diagnostic and analytical detection method
05/10/2007CA2628283A1 Bi-aryl meta-pyrimidine inhibitors of kinases